Journal
SEMINARS IN IMMUNOLOGY
Volume 51, Issue -, Pages -Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.smim.2021.101471
Keywords
HIV; Inflammation; Non-AIDS comorbidities
Categories
Funding
- Intramural Research program of NIAID/NIH
Ask authors/readers for more resources
The use of combination antiretroviral therapy has significantly improved morbidity and mortality in people with HIV, but may not fully restore immune function, leading to non-AIDS comorbidities. Early diagnosis and prompt initiation of therapy at high CD4 counts may be the best approach for improved immune recovery in PWH.
The usage of combination antiretroviral therapy in people with HIV (PWH) has incited profound improvement in morbidity and mortality. Yet, PWH may not experience full restoration of immune function which can manifest with non-AIDS comorbidities that frequently associate with residual inflammation and can imperil quality of life or longevity. In this review, we discuss the pathogenesis underlying chronic inflammation and residual immune dysfunction in PWH, as well as potential therapeutic interventions to ameliorate them and prevent incidence or progression of non-AIDS comorbidities. Current evidence advocates that early diagnosis and prompt initiation of therapy at high CD4 counts may represent the best available approach for an improved immune recovery in PWH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available